小児臨床試験の世界市場レポート 2024年

小児臨床試験市場規模は近年力強く成長しています。2023年の163億1,000万米ドルから2024年には172億9,000万米ドルへと、CAGR6.0％で拡大します。過去数年間に見られた成長は、いくつかの極めて重要な要因によるものです。規制上のインセンティブは、小児の医療ニーズに特化した研究開発を奨励することで、小児医療の進歩を促す上で重要な役割を果たしました。さらに、小児医療におけるアンメット・メディカル・ニーズへの取り組みが技術革新と進歩に拍車をかけ、この分野の成長を刺激しました。小児医療の進歩は、世界の公衆衛生への取り組みと倫理的な要請によって推進され、この成長軌道にさらに貢献しました。特に、小児ワクチン接種プログラムの成功と拡大は、小児のヘルスケア強化に重要な役割を果たし、この期間の全体的な成長に貢献しました。

小児がん患者の増加は、小児臨床試験市場を牽引すると予想されます。小児がんはまれではあるが、成人の腫瘍とは異なる独特の成長パターンを示すため、専門的な調査と治療が必要となります。小児臨床試験は、予後や治療法の進歩に極めて重要な役割を果たしています。米国がん協会の2023年1月の推計によると、米国では15歳未満の小児が約9,910人がんと診断され、2023年には約1,040人が死亡すると予想されています。その結果、ヘルスケア支出の増加が小児臨床試験市場の成長を促進しています。

2023年の小児臨床試験市場で最大の地域は北米です。小児臨床試験市場レポートに掲載されている地域は、アジア太平洋,西欧,東欧,北米,南米,中東,アフリカです。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 マクロ経済シナリオ

• 高インフレが市場に与える影響
• ウクライナ・ロシア戦争が市場に与える影響
• COVID-19による市場への影響

第5章 世界市場規模と成長

• 世界の市場促進要因と抑制要因
  • 市場促進要因
  • 市場抑制要因
• 世界の市場規模実績と成長、2018年～2023年
• 世界の市場規模予測と成長、2023年～2028年、2033年

第6章 市場セグメンテーション

• 世界の小児臨床試験市場、フェーズ別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
• フェーズI
• フェーズII
• フェーズⅢ
• フェーズIV
• 世界の小児臨床試験市場、研究デザイン別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
• 治療研究
• 観察研究
• 世界の小児臨床試験市場、治療領域別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
• 感染症
• 腫瘍学
• 自己免疫疾患または炎症疾患
• 呼吸器疾患
• 精神的健康障害
• その他の治療領域

第7章 地域および国の分析

• 世界の小児臨床試験市場、地域別、実績および予測、2018-2023、2023-2028年、2033年
• 世界の小児臨床試験市場、国別、実績および予測、2018-2023、2023-2028年、2033年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 小児臨床試験市場の競合情勢
• 小児臨床試験市場の企業プロファイル
  • Medpac Inc.
  • Pharmaceutical Product Development Inc.
  • ICON plc
  • Syneos Health Inc.
  • QPS Holdings LLC

第31章 競合ベンチマーキング

第32章 競合ダッシュボード

第33章 主要な合併と買収

第34章 将来の見通しと可能性の分析

第35章 付録

“Pediatric Clinical Trials Global Market Report 2024 ” from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on pediatric clinical trials market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
• Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
• Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
• Measure the impact of high global inflation on market growth.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for pediatric clinical trials? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The pediatric clinical trials market global report ” from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Markets Covered:

• 1) By Phase: Phase I; Phase II; Phase III; Phase IV
• 2) By Study Design: Treatment Studies; Observational Studies
• 3) By Therapeutic Areas: Infectious Diseases; Oncology; Autoimmune Or Inflammatory Diseases; Respiratory Disorders; Mental Health Disorders; Other Therapeutic Areas
• Companies Mentioned: Medpac Inc.; Pharmaceutical Product Development Inc.; ICON plc; Syneos Health Inc.; QPS Holdings LLC
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Executive Summary

Pediatric clinical trials serve as critical investigations into the efficacy, safety, and appropriate dosage of pharmaceuticals, medical devices, and therapies specifically tailored for children. Developing age-appropriate treatments and procedures is paramount in refining and identifying the most effective medical interventions available for pediatric patients.

These trials typically encompass several distinct phases Phase I, Phase II, Phase III, and Phase IV. Phase I trials primarily concentrate on establishing the safety profile and determining the appropriate dosage range of new medications, typically involving 20-100 healthy volunteers. Diverse study designs, such as treatment and observational studies, are employed across various therapeutic areas. These encompass infectious diseases, oncology, autoimmune or inflammatory diseases, respiratory disorders, mental health disorders, among other medical domains, enabling comprehensive exploration and assessment of treatments for pediatric patients.

The pediatric clinical trials market research report is one of a series of new reports from The Business Research Company that provides pediatric clinical trials market statistics, including pediatric clinical trials industry global market size, regional shares, competitors with a pediatric clinical trials market share, detailed pediatric clinical trials market segments, market trends and opportunities, and any further data you may need to thrive in the pediatric clinical trials industry. This pediatric clinical trials market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The pediatric clinical trials market size has grown strongly in recent years. It will grow from $16.31 billion in 2023 to $17.29 billion in 2024 at a compound annual growth rate (CAGR) of 6.0%. The growth observed in the historical period can be ascribed to several pivotal factors. Regulatory incentives played a significant role in incentivizing advancements in pediatric medicine by encouraging research and development tailored specifically to children's medical needs. Additionally, addressing unmet medical needs in pediatric care fueled innovations and advancements, stimulating growth within this domain. Progress in pediatric medicine, driven by global public health initiatives and ethical imperatives, further contributed to this growth trajectory. Notably, the success and expansion of pediatric vaccination programs also played a crucial role in enhancing healthcare for children, thereby contributing to the overall growth observed in this period.

The pediatric clinical trials market size is expected to see strong growth in the next few years. It will grow to $22.52 billion in 2028 at a compound annual growth rate (CAGR) of 6.8%. The growth in the forecast period can be attributed to integration of real-world evidence, pediatric biomarker discovery, expanded access programs, pediatric infectious disease research, pediatric cardiology advancements. Major trends in the forecast period include patient-centric trial design, adoption of adaptive trial designs, digital health technologies, global collaboration and consortia, pediatric oncology advancements.

The rise in pediatric cancer cases is expected to drive the pediatric clinical trials market forward. Pediatric cancers, though rare, exhibit unique growth patterns distinct from adult tumors, necessitating specialized research and treatments. Pediatric clinical trials play a pivotal role in advancing prognosis and treatment methods. According to the American Cancer Society's estimates in January 2023, approximately 9,910 children in the US under 15 will be diagnosed with cancer, with about 1,040 expected deaths in 2023. Consequently, increased healthcare spending fuels the growth of the pediatric clinical trials market.

The burgeoning demand for outsourcing services is set to propel the pediatric clinical trials market's expansion. As preclinical research grows in complexity, pharmaceutical and biotech companies increasingly seek specialized skills beyond their in-house capabilities. Outsourcing services aid in crafting safe, ethical, and scientifically robust pediatric clinical trial protocols. A survey by BioPlan Associates Inc. in April 2023 revealed that around 84.6% of biomanufacturers outsource analytical testing, while 74.5% seek toxicity testing outsourcing, highlighting the surging reliance on outsourcing in pediatric clinical trials, driving market growth.

Product innovation stands out as a pivotal trend reshaping the pediatric clinical trial market. Companies within this sector are investing in innovative products to maintain their market standing. An instance is The Leukemia & Lymphoma Society's launch of the Pediatric Acute Leukemia (PedAL) Master Clinical Trial in June 2022. This groundbreaking trial is tailored to pediatric acute leukemia, leveraging individual tumor biology to match children with the most promising treatments, emphasizing innovation in pediatric cancer research.

Major players in pediatric clinical trials prioritize collaborations and partnerships to deliver dependable services. Strategic partnerships, characterized by structured affiliations between commercial entities, are pivotal in fostering reliability in service provision. Strados Labs' collaboration with Ann & Robert H. Lurie Children's Hospital in September 2023 exemplifies this approach. Their clinical trial involves the RESP Biosensor, a wearable device employing acoustic sensors to monitor lung sounds for asthma symptoms. The trial aims to assess the RESP Biosensor's effectiveness in accurately detecting and monitoring asthma exacerbations in children, showcasing partnerships' role in advancing pediatric healthcare technology.

In December 2021, Thermo Fisher Scientific Inc., a prominent US-based manufacturer specializing in medical devices, analytical instruments, reagents, consumables software, and services, successfully acquired PPD, Inc., for a substantial sum of $17.4 billion. This strategic acquisition significantly bolsters and diversifies Thermo Fisher's portfolio, offering an extensive array of top-tier clinical trial development services. These services span the entire spectrum from scientific discovery to evaluating efficacy, safety, and healthcare outcomes, encompassing clinical trial logistics management and drug product development and manufacturing. PPD, Inc., the acquired entity, operates within the pediatric clinical trials market, serving as a US-based clinical research services provider catering to the biopharma and biotech industries. This strategic move aligns with Thermo Fisher's broader objectives of enhancing its capabilities and expanding its offerings within the clinical trial domain.

Major companies operating in the pediatric clinical trials market report are Medpac Inc., Pharmaceutical Product Development Inc., ICON plc, Syneos Health Inc., QPS Holdings LLC, Pfizer Inc., IQVIA Inc., Premier Research, Labcorp - Laboratory Corporation of America Holdings, The Emmes Company LLC, Synteract Inc., Charles River Laboratories International Inc., Covance Inc., Bristol-Myers Squibb Company, GlaxoSmithKline plc, BioNTech SE, Moderna Inc., Parexel International Corporation, PRA Health Sciences, Wuxi AppTec, Merck & Co. Inc., AstraZeneca plc, Sanofi S.A., Johnson & Johnson, Eli Lilly and Company, Takeda Pharmaceutical Company Limited, C.H. Boehringer Sohn AG & Co. KG, AbbVie Inc., Teva Pharmaceutical Industries Ltd., Oracle Health sciences

North America was the largest region in the pediatric clinical trials market in 2023. The regions covered in the pediatric clinical trials market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the pediatric clinical trials market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The pediatric clinical trials market includes revenues earned by entities through clinical research services, consulting, outsourcing services, and medical communications. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Table of Contents

1. Executive Summary

2. Pediatric Clinical Trials Market Characteristics

3. Pediatric Clinical Trials Market Trends And Strategies

4. Pediatric Clinical Trials Market - Macro Economic Scenario

• 4.1. Impact Of High Inflation On the Market
• 4.2. Ukraine-Russia War Impact On the Market
• 4.3. COVID-19 Impact On the Market

5. Global Pediatric Clinical Trials Market Size and Growth

• 5.1. Global Pediatric Clinical Trials Market Drivers and Restraints
  • 5.1.1. Drivers Of The Market
  • 5.1.2. Restraints Of The Market
• 5.2. Global Pediatric Clinical Trials Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
• 5.3. Global Pediatric Clinical Trials Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Pediatric Clinical Trials Market Segmentation

• 6.1. Global Pediatric Clinical Trials Market, Segmentation By Phase, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Phase I
• Phase II
• Phase III
• Phase IV
• 6.2. Global Pediatric Clinical Trials Market, Segmentation By Study Design, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Treatment Studies
• Observational Studies
• 6.3. Global Pediatric Clinical Trials Market, Segmentation By Therapeutic Areas, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Infectious Diseases
• Oncology
• Autoimmune Or Inflammatory Diseases
• Respiratory Disorders
• Mental Health Disorders
• Other Therapeutic Areas

7. Pediatric Clinical Trials Market Regional And Country Analysis

• 7.1. Global Pediatric Clinical Trials Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 7.2. Global Pediatric Clinical Trials Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Pediatric Clinical Trials Market

• 8.1. Asia-Pacific Pediatric Clinical Trials Market Overview
• Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Pediatric Clinical Trials Market, Segmentation By Phase, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.3. Asia-Pacific Pediatric Clinical Trials Market, Segmentation By Study Design, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.4. Asia-Pacific Pediatric Clinical Trials Market, Segmentation By Therapeutic Areas, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Pediatric Clinical Trials Market

• 9.1. China Pediatric Clinical Trials Market Overview
• 9.2. China Pediatric Clinical Trials Market, Segmentation By Phase, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.3. China Pediatric Clinical Trials Market, Segmentation By Study Design, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.4. China Pediatric Clinical Trials Market, Segmentation By Therapeutic Areas, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Pediatric Clinical Trials Market

• 10.1. India Pediatric Clinical Trials Market, Segmentation By Phase, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.2. India Pediatric Clinical Trials Market, Segmentation By Study Design, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.3. India Pediatric Clinical Trials Market, Segmentation By Therapeutic Areas, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Pediatric Clinical Trials Market

• 11.1. Japan Pediatric Clinical Trials Market Overview
• 11.2. Japan Pediatric Clinical Trials Market, Segmentation By Phase, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.3. Japan Pediatric Clinical Trials Market, Segmentation By Study Design, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.4. Japan Pediatric Clinical Trials Market, Segmentation By Therapeutic Areas, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Pediatric Clinical Trials Market

• 12.1. Australia Pediatric Clinical Trials Market, Segmentation By Phase, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.2. Australia Pediatric Clinical Trials Market, Segmentation By Study Design, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.3. Australia Pediatric Clinical Trials Market, Segmentation By Therapeutic Areas, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Pediatric Clinical Trials Market

• 13.1. Indonesia Pediatric Clinical Trials Market, Segmentation By Phase, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.2. Indonesia Pediatric Clinical Trials Market, Segmentation By Study Design, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.3. Indonesia Pediatric Clinical Trials Market, Segmentation By Therapeutic Areas, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Pediatric Clinical Trials Market

• 14.1. South Korea Pediatric Clinical Trials Market Overview
• 14.2. South Korea Pediatric Clinical Trials Market, Segmentation By Phase, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.3. South Korea Pediatric Clinical Trials Market, Segmentation By Study Design, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.4. South Korea Pediatric Clinical Trials Market, Segmentation By Therapeutic Areas, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Pediatric Clinical Trials Market

• 15.1. Western Europe Pediatric Clinical Trials Market Overview
• 15.2. Western Europe Pediatric Clinical Trials Market, Segmentation By Phase, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.3. Western Europe Pediatric Clinical Trials Market, Segmentation By Study Design, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.4. Western Europe Pediatric Clinical Trials Market, Segmentation By Therapeutic Areas, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Pediatric Clinical Trials Market

• 16.1. UK Pediatric Clinical Trials Market, Segmentation By Phase, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.2. UK Pediatric Clinical Trials Market, Segmentation By Study Design, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.3. UK Pediatric Clinical Trials Market, Segmentation By Therapeutic Areas, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Pediatric Clinical Trials Market

• 17.1. Germany Pediatric Clinical Trials Market, Segmentation By Phase, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.2. Germany Pediatric Clinical Trials Market, Segmentation By Study Design, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.3. Germany Pediatric Clinical Trials Market, Segmentation By Therapeutic Areas, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Pediatric Clinical Trials Market

• 18.1. France Pediatric Clinical Trials Market, Segmentation By Phase, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.2. France Pediatric Clinical Trials Market, Segmentation By Study Design, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.3. France Pediatric Clinical Trials Market, Segmentation By Therapeutic Areas, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Pediatric Clinical Trials Market

• 19.1. Italy Pediatric Clinical Trials Market, Segmentation By Phase, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.2. Italy Pediatric Clinical Trials Market, Segmentation By Study Design, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.3. Italy Pediatric Clinical Trials Market, Segmentation By Therapeutic Areas, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Pediatric Clinical Trials Market

• 20.1. Spain Pediatric Clinical Trials Market, Segmentation By Phase, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.2. Spain Pediatric Clinical Trials Market, Segmentation By Study Design, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.3. Spain Pediatric Clinical Trials Market, Segmentation By Therapeutic Areas, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Pediatric Clinical Trials Market

• 21.1. Eastern Europe Pediatric Clinical Trials Market Overview
• 21.2. Eastern Europe Pediatric Clinical Trials Market, Segmentation By Phase, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.3. Eastern Europe Pediatric Clinical Trials Market, Segmentation By Study Design, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.4. Eastern Europe Pediatric Clinical Trials Market, Segmentation By Therapeutic Areas, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Pediatric Clinical Trials Market

• 22.1. Russia Pediatric Clinical Trials Market, Segmentation By Phase, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.2. Russia Pediatric Clinical Trials Market, Segmentation By Study Design, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.3. Russia Pediatric Clinical Trials Market, Segmentation By Therapeutic Areas, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Pediatric Clinical Trials Market

• 23.1. North America Pediatric Clinical Trials Market Overview
• 23.2. North America Pediatric Clinical Trials Market, Segmentation By Phase, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.3. North America Pediatric Clinical Trials Market, Segmentation By Study Design, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.4. North America Pediatric Clinical Trials Market, Segmentation By Therapeutic Areas, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Pediatric Clinical Trials Market

• 24.1. USA Pediatric Clinical Trials Market Overview
• 24.2. USA Pediatric Clinical Trials Market, Segmentation By Phase, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.3. USA Pediatric Clinical Trials Market, Segmentation By Study Design, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.4. USA Pediatric Clinical Trials Market, Segmentation By Therapeutic Areas, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Pediatric Clinical Trials Market

• 25.1. Canada Pediatric Clinical Trials Market Overview
• 25.2. Canada Pediatric Clinical Trials Market, Segmentation By Phase, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.3. Canada Pediatric Clinical Trials Market, Segmentation By Study Design, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.4. Canada Pediatric Clinical Trials Market, Segmentation By Therapeutic Areas, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Pediatric Clinical Trials Market

• 26.1. South America Pediatric Clinical Trials Market Overview
• 26.2. South America Pediatric Clinical Trials Market, Segmentation By Phase, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.3. South America Pediatric Clinical Trials Market, Segmentation By Study Design, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.4. South America Pediatric Clinical Trials Market, Segmentation By Therapeutic Areas, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Pediatric Clinical Trials Market

• 27.1. Brazil Pediatric Clinical Trials Market, Segmentation By Phase, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.2. Brazil Pediatric Clinical Trials Market, Segmentation By Study Design, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.3. Brazil Pediatric Clinical Trials Market, Segmentation By Therapeutic Areas, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Pediatric Clinical Trials Market

• 28.1. Middle East Pediatric Clinical Trials Market Overview
• 28.2. Middle East Pediatric Clinical Trials Market, Segmentation By Phase, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.3. Middle East Pediatric Clinical Trials Market, Segmentation By Study Design, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.4. Middle East Pediatric Clinical Trials Market, Segmentation By Therapeutic Areas, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Pediatric Clinical Trials Market

• 29.1. Africa Pediatric Clinical Trials Market Overview
• 29.2. Africa Pediatric Clinical Trials Market, Segmentation By Phase, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.3. Africa Pediatric Clinical Trials Market, Segmentation By Study Design, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.4. Africa Pediatric Clinical Trials Market, Segmentation By Therapeutic Areas, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Pediatric Clinical Trials Market Competitive Landscape And Company Profiles

• 30.1. Pediatric Clinical Trials Market Competitive Landscape
• 30.2. Pediatric Clinical Trials Market Company Profiles
  • 30.2.1. Medpac Inc.
    • 30.2.1.1. Overview
    • 30.2.1.2. Products and Services
    • 30.2.1.3. Strategy
    • 30.2.1.4. Financial Performance
  • 30.2.2. Pharmaceutical Product Development Inc.
    • 30.2.2.1. Overview
    • 30.2.2.2. Products and Services
    • 30.2.2.3. Strategy
    • 30.2.2.4. Financial Performance
  • 30.2.3. ICON plc
    • 30.2.3.1. Overview
    • 30.2.3.2. Products and Services
    • 30.2.3.3. Strategy
    • 30.2.3.4. Financial Performance
  • 30.2.4. Syneos Health Inc.
    • 30.2.4.1. Overview
    • 30.2.4.2. Products and Services
    • 30.2.4.3. Strategy
    • 30.2.4.4. Financial Performance
  • 30.2.5. QPS Holdings LLC
    • 30.2.5.1. Overview
    • 30.2.5.2. Products and Services
    • 30.2.5.3. Strategy
    • 30.2.5.4. Financial Performance

31. Global Pediatric Clinical Trials Market Competitive Benchmarking

32. Global Pediatric Clinical Trials Market Competitive Dashboard

33. Key Mergers And Acquisitions In The Pediatric Clinical Trials Market

34. Pediatric Clinical Trials Market Future Outlook and Potential Analysis

• 34.1 Pediatric Clinical Trials Market In 2028 - Countries Offering Most New Opportunities
• 34.2 Pediatric Clinical Trials Market In 2028 - Segments Offering Most New Opportunities
• 34.3 Pediatric Clinical Trials Market In 2028 - Growth Strategies
  • 34.3.1 Market Trend Based Strategies
  • 34.3.2 Competitor Strategies

35. Appendix

• 35.1. Abbreviations
• 35.2. Currencies
• 35.3. Historic And Forecast Inflation Rates
• 35.4. Research Inquiries
• 35.5. The Business Research Company
• 35.6. Copyright And Disclaimer